Inhibition of BMK1 pathway suppresses cancer stem cells through BNIP3 and BNIP3L

Cancer stem cells (CSCs) possess many characteristics associated with stem cells and are believed to drive tumor initiation. Although targeting of CSCs offers great promise for the new generation of therapeutics, lack of the effective drugable target and appropriate pharmacological reagents signific...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Oncotarget
Hauptverfasser: Song, Chengli, Xu, Qiang, Jiang, Kui, Zhou, Guangyu, Yu, Xuebin, Wang, Lina, Zhu, Yuting, Fang, Liping, Yu, Zhe, Lee, Jiing-Dwan, Yu, Shi-Cang, Yang, Qingkai
Format: Artigo
Sprache:Inglês
Veröffentlicht: Impact Journals LLC 2015
Schlagworte:
Research Paper
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4741765/
https://ncbi.nlm.nih.gov/pubmed/26432836
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge